Page last updated: 2024-08-18

pyrazolanthrone and Leukemia, Myeloid, Acute

pyrazolanthrone has been researched along with Leukemia, Myeloid, Acute in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breslin, P; Chen, J; Kuo, PC; Li, J; Li, X; Li, Z; Liu, X; Nand, S; Schmidt, R; Volk, A; Wei, W; Xiao, Y; Xin, J; You, D; Zhang, J; Zhang, Z	1
Barbetti, V; Dello Sbarba, P; Giuntoli, S; Gozzini, A; Rovida, E; Santini, V	1

Other Studies

2 other study(ies) available for pyrazolanthrone and Leukemia, Myeloid, Acute

Article	Year
Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML. The Journal of experimental medicine, 2014, Jun-02, Volume: 211, Issue:6 Topics: Animals; Anthracenes; Blotting, Western; Cell Line, Tumor; Cell Survival; Cells, Cultured; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Mice; Mice, Knockout; NF-kappa B; Nitriles; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfones; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; U937 Cells	2014
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. British journal of haematology, 2006, Volume: 135, Issue:5 Topics: Anthracenes; Apoptosis; Blotting, Western; Butyrates; Caspase 8; Cell Line, Tumor; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Histone Deacetylase Inhibitors; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid, Acute; Mannose; p38 Mitogen-Activated Protein Kinases; Pyridines; Translocation, Genetic	2006

Article

Year

Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.

The Journal of experimental medicine, 2014, Jun-02, Volume: 211, Issue:6

Topics: Animals; Anthracenes; Blotting, Western; Cell Line, Tumor; Cell Survival; Cells, Cultured; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Mice; Mice, Knockout; NF-kappa B; Nitriles; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfones; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; U937 Cells

2014

The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells.

British journal of haematology, 2006, Volume: 135, Issue:5

Topics: Anthracenes; Apoptosis; Blotting, Western; Butyrates; Caspase 8; Cell Line, Tumor; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Histone Deacetylase Inhibitors; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid, Acute; Mannose; p38 Mitogen-Activated Protein Kinases; Pyridines; Translocation, Genetic

2006